A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK options ...

MERCK & CO INC (MRK) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 90% based on the firm’s underlying fundamentals and the stock’s valuation.

But AstraZeneca stock fell in line with pharma stocks. Merck (NYSE:MRK) recently presented promising results from the Phase 3 ZENITH trial for its drug WINREVAIR, but the company's stock ...

We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look ...

Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios.

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno ...

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks. Merck (NYSE:MRK) recently presented promising results from ...

US President Donald Trump’s sudden, shocking 90-day pause on his so-called “reciprocal” tariffs (they were not reciprocal) ...

SEC Filings provided by EDGAR Online, Inc.